These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 14634073)

  • 1. Cutting edge: transplantation tolerance through enhanced CTLA-4 expression.
    Ariyan C; Salvalaggio P; Fecteau S; Deng S; Rogozinski L; Mandelbrot D; Sharpe A; Sayegh MH; Basadonna GP; Rothstein DM
    J Immunol; 2003 Dec; 171(11):5673-7. PubMed ID: 14634073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen exposure during enhanced CTLA-4 expression promotes allograft tolerance in vivo.
    Salvalaggio PR; Camirand G; Ariyan CE; Deng S; Rogozinski L; Basadonna GP; Rothstein DM
    J Immunol; 2006 Feb; 176(4):2292-8. PubMed ID: 16455985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTLA-4 up-regulation plays a role in tolerance mediated by CD45.
    Fecteau S; Basadonna GP; Freitas A; Ariyan C; Sayegh MH; Rothstein DM
    Nat Immunol; 2001 Jan; 2(1):58-63. PubMed ID: 11135579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
    Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
    J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
    Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
    J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.
    Zheng XX; Markees TG; Hancock WW; Li Y; Greiner DL; Li XC; Mordes JP; Sayegh MH; Rossini AA; Strom TB
    J Immunol; 1999 Apr; 162(8):4983-90. PubMed ID: 10202046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD45RB antibody deters xenograft rejection by modulating T cell priming and homing.
    Sutherland RM; McKenzie BS; Zhan Y; Corbett AJ; Fox-Marsh A; Georgiou HM; Harrison LC; Lew AM
    Int Immunol; 2002 Aug; 14(8):953-62. PubMed ID: 12147632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance.
    Phillips NE; Markees TG; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2003 Mar; 170(6):3015-23. PubMed ID: 12626555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting signal 1 through CD45RB synergizes with CD40 ligand blockade and promotes long term engraftment and tolerance in stringent transplant models.
    Rothstein DM; Livak MF; Kishimoto K; Ariyan C; Qian HY; Fecteau S; Sho M; Deng S; Zheng XX; Sayegh MH; Basadonna GP
    J Immunol; 2001 Jan; 166(1):322-9. PubMed ID: 11123308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Sharpe AH; Vallera DA
    J Immunol; 1999 Jun; 162(11):6368-77. PubMed ID: 10352249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA-4-Ig regulates tryptophan catabolism in vivo.
    Grohmann U; Orabona C; Fallarino F; Vacca C; Calcinaro F; Falorni A; Candeloro P; Belladonna ML; Bianchi R; Fioretti MC; Puccetti P
    Nat Immunol; 2002 Nov; 3(11):1097-101. PubMed ID: 12368911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.
    Bonham CA; Peng L; Liang X; Chen Z; Wang L; Ma L; Hackstein H; Robbins PD; Thomson AW; Fung JJ; Qian S; Lu L
    J Immunol; 2002 Sep; 169(6):3382-91. PubMed ID: 12218160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolongation of allograft survival of transfected islets expressing human CTLA4-Ig, human soluble Fas ligand or a combination of the two.
    Gainer AL; Suarez-Pinzon WL; Min WP; Hancock-Friesen C; Korbutt GS; Rajotte RV; Rabinovitch A; Warnock GL; Elliott JF
    Transplant Proc; 1998 Mar; 30(2):534. PubMed ID: 9532165
    [No Abstract]   [Full Text] [Related]  

  • 14. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
    Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
    J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CTLA4-Ig by biolistically transfected mouse islets promotes islet allograft survival.
    Gainer AL; Korbutt GS; Rajotte RV; Warnock GL; Elliott JF
    Transplantation; 1997 Apr; 63(7):1017-21. PubMed ID: 9112357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts.
    Mandelbrot DA; Furukawa Y; McAdam AJ; Alexander SI; Libby P; Mitchell RN; Sharpe AH
    J Immunol; 1999 Oct; 163(7):3753-7. PubMed ID: 10490971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
    Lin H; Rathmell JC; Gray GS; Thompson CB; Leiden JM; Alegre ML
    J Exp Med; 1998 Jul; 188(1):199-204. PubMed ID: 9653096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell depletion improves islet allograft survival with anti-CD45RB.
    Lee KM; Yeh H; Zhao G; Wei L; O'Connor M; Stott RT; Soohoo J; Dunussi K; Fiorina P; Deng S; Markmann JF; Kim JI
    Cell Transplant; 2014 Jan; 23(1):51-8. PubMed ID: 23192154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD28-independent costimulation of T cells in alloimmune responses.
    Yamada A; Kishimoto K; Dong VM; Sho M; Salama AD; Anosova NG; Benichou G; Mandelbrot DA; Sharpe AH; Turka LA; Auchincloss H; Sayegh MH
    J Immunol; 2001 Jul; 167(1):140-6. PubMed ID: 11418642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.
    Kingsley CI; Karim M; Bushell AR; Wood KJ
    J Immunol; 2002 Feb; 168(3):1080-6. PubMed ID: 11801641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.